The Global Biomarker Discovery Outsourcing Services Market Size is Expected to reach USD 34.2 Billion by 2033, at a CAGR of 10.41% during the forecast period 2023 to 2033.The biomarker discovery outsourcing services market includes a variety of services provided by contract research organisations (CROs) and other specialised firms to pharmaceutical, biotechnology, and academic institutions in identifying and validating biomarkers for a variety of applications such as drug discovery and development, diagnostics, personalised medicine, and prognostics. The demand for biomarker discovery services is increasing as the focus shifts to precision medicine, personalised medicines, and the need for predictive and prognostic tools in healthcare